COVID-19 Update (Details) - USD ($)			12 Months Ended
	Jun. 10, 2021	Apr. 16, 2020	Dec. 31, 2021	Dec. 31, 2020	Feb. 23, 2018
Unusual or Infrequent Item, or Both [Line Items]
Increase (decrease) in revenue			$ (2,700,000)	$ 38,100,000
Increase (decrease) in revenue, percentage of sales			1.00%
Gain on forgiveness of debt			$ 5,000,000	0
Proceeds from issuance of common stock in connection with initial public offering, net of issuance costs			67,592,000	0
Repayments of lines of credit			34,639,000	0
Repayments of long-term debt			39,272,000	7,364,000
Cash and cash equivalents			6,483,000	$ 448,000
Line of credit
Unusual or Infrequent Item, or Both [Line Items]
Repayments of lines of credit			34,600,000
Maximum borrowing			40,000,000		$ 40,000,000
Paycheck Protection Program, CARES Act
Unusual or Infrequent Item, or Both [Line Items]
Loan proceeds received		$ 5,000,000
Gain on forgiveness of debt	$ 5,000,000
Certain Term Loans
Unusual or Infrequent Item, or Both [Line Items]
Repayments of long-term debt			39,300,000
Term Loan, Maturing September 30, 2026
Unusual or Infrequent Item, or Both [Line Items]
Term loan, accordion feature			$ 6,885,000